- Home
- NCRA vs EDSA Comparison
NCRA vs EDSA Comparison
Compare NCRA & EDSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NCRA
- EDSA
- Stock Information
- Founded
- NCRA 2002
- EDSA 2015
- Country
- NCRA Taiwan
- EDSA Canada
- Employees
- NCRA N/A
- EDSA N/A
- Industry
- NCRA Farming/Seeds/Milling
- EDSA Biotechnology: Pharmaceutical Preparations
- Sector
- NCRA Consumer Staples
- EDSA Health Care
- Exchange
- NCRA Nasdaq
- EDSA Nasdaq
- Market Cap
- NCRA 12.6M
- EDSA 6.1M
- IPO Year
- NCRA N/A
- EDSA N/A
- Fundamental
- Price
- NCRA $0.82
- EDSA $1.73
- Analyst Decision
- NCRA
- EDSA Strong Buy
- Analyst Count
- NCRA 0
- EDSA 1
- Target Price
- NCRA N/A
- EDSA $21.00
- AVG Volume (30 Days)
- NCRA 8.2K
- EDSA 30.6K
- Earning Date
- NCRA 08-14-2024
- EDSA 02-07-2025
- Dividend Yield
- NCRA N/A
- EDSA N/A
- EPS Growth
- NCRA N/A
- EDSA N/A
- EPS
- NCRA N/A
- EDSA N/A
- Revenue
- NCRA $20,483,694.00
- EDSA N/A
- Revenue This Year
- NCRA N/A
- EDSA N/A
- Revenue Next Year
- NCRA N/A
- EDSA N/A
- P/E Ratio
- NCRA N/A
- EDSA N/A
- Revenue Growth
- NCRA N/A
- EDSA N/A
- 52 Week Low
- NCRA $0.70
- EDSA $1.55
- 52 Week High
- NCRA $1.54
- EDSA $5.99
- Technical
- Relative Strength Index (RSI)
- NCRA 41.47
- EDSA 31.51
- Support Level
- NCRA $0.76
- EDSA $1.73
- Resistance Level
- NCRA $1.14
- EDSA $1.99
- Average True Range (ATR)
- NCRA 0.11
- EDSA 0.19
- MACD
- NCRA -0.01
- EDSA 0.02
- Stochastic Oscillator
- NCRA 35.82
- EDSA 18.00
About NCRA Nocera Inc.
Nocera Inc is engaged in the manufacturing of aquaculture equipment, construction of aquaculture facilities, managing and operating aquaculture facilities, and consulting for third-party operators of aquaculture facilities. Its primary business operations consist of the design, development, and production of RASs large-scale fish tank systems, for fish farms along with expert consulting, technology transfer, and aquaculture project management services to new and existing aquaculture management business services.
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB01, is a non-steroidal, anti-inflammatory treatment for chronic allergic contact dermatitis. The company operates in a single segment: research and development, manufacturing, and commercialization of innovative pharmaceutical products. The company's EB05 candidate is a monoclonal antibody therapy for hospitalized COVID-19 patients.